Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

NCT00539526 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00539526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00539526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
September 30, 2008
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open angle glaucoma